| human | Q5 |
| P496 | ORCID iD | 0000-0003-1500-4058 |
| P10069 | Tabakalera ID | 134841 |
| P69 | educated at | University of Santiago de Compostela | Q1473677 |
| San Raffaele Hospital | Q3145229 | ||
| P108 | employer | University of Santiago de Compostela | Q1473677 |
| Vigo University | Q666916 | ||
| P734 | family name | Alvarez | Q25261946 |
| Alvarez | Q25261946 | ||
| Alvarez | Q25261946 | ||
| P735 | given name | Clara | Q1114146 |
| Clara | Q1114146 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q27350395 | A GRFa2/Prop1/stem (GPS) cell niche in the pituitary |
| Q71441786 | Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli |
| Q39452029 | Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors. |
| Q37279455 | Deletion of miRNA processing enzyme Dicer in POMC-expressing cells leads to pituitary dysfunction, neurodegeneration and development of obesity. |
| Q92583126 | Early evolutionary divergence between papillary and anaplastic thyroid cancers |
| Q72224054 | Effect of neurotensin on growth hormone release in vivo |
| Q38109372 | Energy balance regulation by thyroid hormones at central level |
| Q41535557 | Expression of epithelial phenotype is enhanced by v-Ha-ras in rat endometrial cells immortalized by SV40 T antigen. |
| Q82737503 | Expression of exogenous proteins and short hairpin RNAs in human primary thyrocytes |
| Q48066875 | Future perspectives in adult stem cell turnover: Implications for endocrine physiology and disease |
| Q40066910 | GHRH proliferative action on somatotrophs is cell-type specific and dependent on Pit-1/GHF-1 expression. |
| Q81479487 | Ghrelin localization in the medulla of rat and human adrenal gland and in pheochromocytomas |
| Q38254396 | Hypothalamic effects of thyroid hormones on metabolism. |
| Q51448625 | Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. |
| Q60527078 | Identification of a paired box gene 8–peroxisome proliferator-activated receptor gamma (PAX8–PPARγ) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH recept |
| Q43816689 | Localization of growth hormone receptors in rat and human thyroid cells. |
| Q42261935 | MKK6 controls T3-mediated browning of white adipose tissue |
| Q91069357 | Mechanistic investigations into the encapsulation and release of small molecules and proteins from a supramolecular nucleoside gel in vitro and in vivo |
| Q112290479 | Mitochondrial cristae-remodeling protein OPA1 in POMC neurons couples Ca2+ homeostasis with adipose tissue lipolysis |
| Q38770668 | Pharmacological and Genetic Manipulation of p53 in Brown Fat at Adult But Not Embryonic Stages Regulates Thermogenesis and Body Weight in Male Mice |
| Q60545962 | Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin |
| Q28080442 | Pituitary Cell Turnover: From Adult Stem Cell Recruitment through Differentiation to Death |
| Q40353033 | Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinoma. |
| Q28610001 | Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites |
| Q57812469 | Protamine nanocapsules as carriers for oral peptide delivery |
| Q41512072 | Prothymosin alpha mRNA is expressed in competent and proliferating rat thyroid cells (FRTL-5) but is not sufficient to elicit cell progression through the cell cycle. |
| Q42819958 | Prothymosin alpha mRNA levels are invariant throughout the cell cycle |
| Q72586219 | Regulation of prothymosin alpha mRNA levels in rat pituitary tumor cells |
| Q51620108 | Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer. |
| Q36767365 | Role of ghrelin in reproduction. |
| Q103831876 | Sequential Colocalization of ERa, PR, and AR Hormone Receptors Using Confocal Microscopy Enables New Insights into Normal Breast and Prostate Tissue and Cancers |
| Q28573071 | Sirt1 inhibits the transcription factor CREB to regulate pituitary growth hormone synthesis |
| Q38964671 | Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF. |
| Q42826060 | Structural Requirements of the Epidermal Growth Factor Receptor for Tyrosine Phosphorylation of eps8 and eps15, Substrates Lacking Src SH2 Homology Domains |
| Q79227602 | TGF-beta-induced apoptosis in human thyrocytes is mediated by p27kip1 reduction and is overridden in neoplastic thyrocytes by NF-kappaB activation |
| Q41054493 | TGF-beta1 actions on FRTL-5 cells provide a model for the physiological regulation of thyroid growth. |
| Q115193317 | Tackling Thyroid Cancer in Europe-The Challenges and Opportunities |
| Q38879404 | The Molecular Registry of Pituitary Adenomas (REMAH): A bet of Spanish Endocrinology for the future of individualized medicine and translational research. |
| Q35752727 | The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth. |
| Q47993894 | The orexigenic effect of orexin-A revisited: dependence of an intact growth hormone axis. |
| Q37681876 | The syndrome of central hypothyroidism and macroorchidism: IGSF1 controls TRHR and FSHB expression by differential modulation of pituitary TGFβ and Activin pathways. |
| Q64964321 | Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly. |
| Q90772646 | Why Should Growth Hormone (GH) Be Considered a Promising Therapeutic Agent for Arteriogenesis? Insights from the GHAS Trial |
Search more.